The SIK2 overexpression group exhibited a much faster tumor growth than the control group, whereas the tumor growth-promoting effect of SIK2 was attenuated by knockdown of SREBP1c or SREBP2 (Fig. 6g, h). The gene discussed is SREBF2; the disease is neoplasm.